Liquidia (LQDA) Long-Term Debt Repayments (2020 - 2026)
Liquidia (LQDA) recorded quarterly Long-Term Debt Repayments of $20.0 million in Q1 2026, up 147.85% quarter-over-quarter from $8.1 million in Q4 2025, and up 841.05% on a YoY basis from $2.1 million in Q1 2025.
Liquidia (LQDA) Long-Term Debt Repayments (2020 - 2026) Analysis & Trends
Liquidia's Long-Term Debt Repayments history runs 7 years deep, the most recent figure standing at $20.0 million for Q1 2026.
- In Q1 2026, Long-Term Debt Repayments rose 841.05% year-over-year to $20.0 million; the TTM figure through Mar 2026 stood at $38.9 million (up 515.99% YoY), while the FY2025 annual figure was $21.1 million, up 334.58% from the prior year.
- Long-Term Debt Repayments was $20.0 million for Q1 2026 at Liquidia, up from $8.1 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $20.0 million in Q1 2023 to a low of -$10.5 million in Q3 2022.
- Historically, Long-Term Debt Repayments has averaged $5.6 million across 5 years, with a median of $2.5 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Long-Term Debt Repayments tumbled 96.73% in 2024, then jumped 841.05% in 2026.
- A 5-year view of Long-Term Debt Repayments shows it stood at $10.5 million in 2022, then plunged by 84.25% to $1.7 million in 2023, then climbed by 28.3% to $2.1 million in 2024, then soared by 279.69% to $8.1 million in 2025, then jumped by 147.85% to $20.0 million in 2026.
- The last three Long-Term Debt Repayments figures came in at $20.0 million (Q1 2026), $8.1 million (Q4 2025), and $8.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 23.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 216,000.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 19.97 Mn |
| 10 | Hims & Hers Health | 6.15 Bn | 5.40 Bn | 396.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.97 Mn |
| Mar 31, 2026 | 19.97 Mn |
| Dec 31, 2025 | 8.06 Mn |
| Dec 31, 2025 | 8.06 Mn |
| Sep 30, 2025 | 8.06 Mn |
| Sep 30, 2025 | 8.06 Mn |
| Jun 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 2.85 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 654,000.00 |
| Mar 31, 2024 | 654,000.00 |
| Dec 31, 2023 | 1.65 Mn |
| Dec 31, 2023 | 1.65 Mn |